![]() Corvidia Therapeutics Corvidia Therapeutics is a biotechnology company. It develops next-generation precision cardiovascular therapies. | ![]() Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. | ![]() Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | |||
Founding Date | Founding Date 2015 | Founding Date 2015 | Founding Date 1995 | Founding Date 2019 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Waltham, US HQ | Locations South San Francisco, US HQ | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations South San Francisco, US HQ | Locations Cambridge, US HQ |
Employees | Employees 5 | Employees 49 | Employees 4742% decrease | Employees 2613% increase | Employees 992% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) 821 k | Valuation ($) N/A | Valuation ($) 2.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $22.9m (FY, 2021) |
Net income | Net income N/A | Net income ($126.3m) (FY, 2022) | Net income ($252.9m) (FY, 2023) | Net income N/A | Net income ($37.2m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 86m | Total funding raised $ 72.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 168.5m |

Applied Molecular Transport (AMT) is a biopharmaceutical company.
View company
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyCellares is a provider of cell therapy manufacturing services.
View company
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company